Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Maric, Nadja (57226219191)"

Filter results by typing the first few letters
Now showing 1 - 6 of 6
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A preliminary evaluation of leukocyte phospho-glucocorticoid receptor as a potential biomarker of depressogenic vulnerability in healthy adults
    (2013)
    Simic, Iva (56387693600)
    ;
    Adzic, Miroslav (14048072500)
    ;
    Maric, Nadja (57226219191)
    ;
    Savic, Danka (25948987000)
    ;
    Djordjevic, Jelena (7003425004)
    ;
    Mihaljevic, Marina (55345716000)
    ;
    Mitic, Milos (6603848725)
    ;
    Pavlovic, Zorana (24831071100)
    ;
    Soldatovic, Ivan (35389846900)
    ;
    Krstic-Demonacos, Marija (6603442405)
    ;
    Jasovic-Gasic, Miroslava (55945351100)
    ;
    Radojcic, Marija (55905480100)
    The mechanism of maladaptive chronic stress response involves altered phosphorylation of the glucocorticoid receptor (GR). In this study, we investigated if important depressogenic vulnerability factors, such as neuroticism and self-reports of negative affective states, may be associated with alterations in levels of the GR and GR phosphoisoforms in peripheral blood mononuclear cells (PBMC) of healthy adults. In 21 women and 16 men we evaluated PMBC levels of total GR (tGR), GR phosphorylated at serine 211 (pGR-S211) and serine 226 (pGR-S226) and correlated these data with personality traits and current reports of stress, anxiety and depression. Also, we assessed plasma cortisol levels in all tested subjects. Our results showed that in women nuclear pGR-S226 was positively correlated with neuroticism and current reports of depression, anxiety and stress, while the ratio of nuclear pGR-S211/pGR-S226 was negatively correlated with reports of depression. None of the aforementioned correlations were significant in men. No significant relations between cortisol levels and any of GR parameters were observed. These preliminary findings highlight the value of GR phosphorylation-related research in identifying molecular biomarkers of depressogenic vulnerability, at least in women. © 2013 Elsevier Ireland Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A preliminary evaluation of leukocyte phospho-glucocorticoid receptor as a potential biomarker of depressogenic vulnerability in healthy adults
    (2013)
    Simic, Iva (56387693600)
    ;
    Adzic, Miroslav (14048072500)
    ;
    Maric, Nadja (57226219191)
    ;
    Savic, Danka (25948987000)
    ;
    Djordjevic, Jelena (7003425004)
    ;
    Mihaljevic, Marina (55345716000)
    ;
    Mitic, Milos (6603848725)
    ;
    Pavlovic, Zorana (24831071100)
    ;
    Soldatovic, Ivan (35389846900)
    ;
    Krstic-Demonacos, Marija (6603442405)
    ;
    Jasovic-Gasic, Miroslava (55945351100)
    ;
    Radojcic, Marija (55905480100)
    The mechanism of maladaptive chronic stress response involves altered phosphorylation of the glucocorticoid receptor (GR). In this study, we investigated if important depressogenic vulnerability factors, such as neuroticism and self-reports of negative affective states, may be associated with alterations in levels of the GR and GR phosphoisoforms in peripheral blood mononuclear cells (PBMC) of healthy adults. In 21 women and 16 men we evaluated PMBC levels of total GR (tGR), GR phosphorylated at serine 211 (pGR-S211) and serine 226 (pGR-S226) and correlated these data with personality traits and current reports of stress, anxiety and depression. Also, we assessed plasma cortisol levels in all tested subjects. Our results showed that in women nuclear pGR-S226 was positively correlated with neuroticism and current reports of depression, anxiety and stress, while the ratio of nuclear pGR-S211/pGR-S226 was negatively correlated with reports of depression. None of the aforementioned correlations were significant in men. No significant relations between cortisol levels and any of GR parameters were observed. These preliminary findings highlight the value of GR phosphorylation-related research in identifying molecular biomarkers of depressogenic vulnerability, at least in women. © 2013 Elsevier Ireland Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clozapine prescription rates in Southeast Europe: A cross-sectional study
    (2023)
    Russo, Manuela (35764063200)
    ;
    Ignjatovic-Ristic, Dragana (55102897100)
    ;
    Cohen, Dan (7404418408)
    ;
    Arenliu, Aliriza (55897294800)
    ;
    Bajraktarov, Stojan (51460959700)
    ;
    Dzubur Kulenovic, Alma (56618369100)
    ;
    Injac Stevovic, Lidija (37079647600)
    ;
    Maric, Nadja (57226219191)
    ;
    Novotni, Antoni (6507294296)
    ;
    Jovanovic, Nikolina (22956210600)
    Introduction: International reports indicate that clozapine is under prescribed. Yet, this has not been explored in Southeast European (SEE) countries. This cross-sectional study investigates clozapine prescription rates in a sample of 401 outpatients with psychosis from Bosnia and Herzegovina, Kosovo by United Nations resolution, North Macedonia, Montenegro and Serbia. Methods: Descriptive analysis was used to explore clozapine prescription rates; daily antipsychotic dosage was calculated and converted into olanzapine equivalents. Patients receiving clozapine were compared to those not receiving clozapine; next those that were on clozapine monotherapy were compared to those who were on clozapine polytherapy regime. Results: It was showed that clozapine was prescribed to 37.7% of patients (with cross-country variation: from 25% in North Macedonia to 43.8% in Montenegro), with average dose of 130.7 mg/daily. The majority of patients on clozapine (70.5%) were prescribed at least one more antipsychotic (the most frequent combination was with haloperidol). Discussion: Our findings suggested that clozapine prescription rate in SEE outpatients is higher than in Western Europe. The average dose is significantly below the optimal therapeutic dosage recommended by clinical guidelines, and clozapine polytherapy is common. This might indicate that clozapine is prescribed mainly for its sedative effect rather than antipsychotic. We hope that this finding will be taken up by relevant stakeholders to address this non-evidence-based practice. Copyright © 2023 Russo, Ignjatovic-Ristic, Cohen, Arenliu, Bajraktarov, Dzubur Kulenovic, Injac Stevovic, Maric, Novotni and Jovanovic.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Pathways to psychiatric care in Eastern Europe
    (2005)
    Gater, Richard (10243740800)
    ;
    Jordanova, Vesna (12770411200)
    ;
    Maric, Nadja (57226219191)
    ;
    Alikaj, Valbona (8571554200)
    ;
    Bajs, Maja (15030500100)
    ;
    Cavic, Tamara (8571554400)
    ;
    Dimitrov, Hristo (8571554500)
    ;
    Iosub, Diana (8571554600)
    ;
    Mihai, Adriana (23474301400)
    ;
    Szalontay, Andreea Silvana (6507078717)
    ;
    Helmchen, Hanfried (7004489815)
    ;
    Sartorius, Norman (7102159482)
    Background: There has been almost no research into mental health services in Eastern Europe. A pathways study is a quick and useful starting point, requiring few resources. Aims: To improve understanding of prior care-seeking and treatment of new patients seen at mental health services. Method: Pathways diagrams were drawn showing the routes of care-seeking for 50 new patients in eight centres. Patterns of care-seeking, durations and previous treatments were compared for ICD-10 diagnostic groups. Results: The diagnoses varied according to the organisation of services. Major pathways included general practitioners, direct access and hospital doctors. General practitioners have a limited role as 'gatekeeper' in centres in Albania, Croatia, Macedonia, Romania and Serbia-Montenegro, and rarely prescribed treatment, except sedatives, for mental disorders. Conclusions: Findings highlight areas that require attention if aspirations for community-oriented mental health care are to be realised, particularly integration of mental health into primary care.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe
    (2022)
    Correll, Christoph U. (57203102810)
    ;
    Fusar-Poli, Paolo (10044017500)
    ;
    Leucht, Stefan (7003761080)
    ;
    Karow, Anne (7004309858)
    ;
    Maric, Nadja (57226219191)
    ;
    Moreno, Carmen (56817942600)
    ;
    Nordentoft, Merete (7006191523)
    ;
    Raballo, Andrea (6602259569)
    Purpose: Although first-episode psychosis (FEP) in youth, particularly early-onset schizophrenia (EOS), is managed similarly to adult-onset schizophrenia, few antipsychotics are approved for people aged 13–18 years. We aimed to explore areas of uncertainty in EOS management and provide evidence-based recommendations to mental health specialists. We used the Delphi methodology to gain knowledge in areas lacking evidence-based strategies. This standardized methodology consists of the development of a questionnaire by content experts, which is then submitted to a broader panel of professionals (panelists) to survey their level of agreement on the topics proposed. Materials and Methods: The developed questionnaire covered patient management from diagnosis to maintenance treatment and was administered to a broader panel of specialists across Europe. Based on an analysis of responses received in this first round, the items that needed further insight were submitted to the panel for a second round and then reanalysed. Results: An initial set of 90 items was developed; in round I, consensus was reached for 83/90 items (92%), while it was reached for 7/11 (64%) of the items sent out for rerating in round II. Feedback for rounds I and II was obtained from 54/92 and 48/54 approached experts, respectively. There was broad agreement on diagnostic standards, multimodal approaches and focus on adverse events, but uncertainty in terms of pharmacological strategies (including clozapine) in case of failure and antipsychotic dosing in younger patients. Conclusion: Despite knowledge about diagnostic clues and integrated management of EOS, this study highlights the lack of standardization in treating EOS, with safety arguments having a major role in the decision-making process. Targeted clinical trials and systematic dissemination across Europe of current scientific evidence on the value of early intervention services is hoped to contribute to standardized and improved quality care for patients with early-phase psychosis and schizophrenia. © 2022 Correll et al.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe
    (2022)
    Correll, Christoph U. (57203102810)
    ;
    Fusar-Poli, Paolo (10044017500)
    ;
    Leucht, Stefan (7003761080)
    ;
    Karow, Anne (7004309858)
    ;
    Maric, Nadja (57226219191)
    ;
    Moreno, Carmen (56817942600)
    ;
    Nordentoft, Merete (7006191523)
    ;
    Raballo, Andrea (6602259569)
    Purpose: Although first-episode psychosis (FEP) in youth, particularly early-onset schizophrenia (EOS), is managed similarly to adult-onset schizophrenia, few antipsychotics are approved for people aged 13–18 years. We aimed to explore areas of uncertainty in EOS management and provide evidence-based recommendations to mental health specialists. We used the Delphi methodology to gain knowledge in areas lacking evidence-based strategies. This standardized methodology consists of the development of a questionnaire by content experts, which is then submitted to a broader panel of professionals (panelists) to survey their level of agreement on the topics proposed. Materials and Methods: The developed questionnaire covered patient management from diagnosis to maintenance treatment and was administered to a broader panel of specialists across Europe. Based on an analysis of responses received in this first round, the items that needed further insight were submitted to the panel for a second round and then reanalysed. Results: An initial set of 90 items was developed; in round I, consensus was reached for 83/90 items (92%), while it was reached for 7/11 (64%) of the items sent out for rerating in round II. Feedback for rounds I and II was obtained from 54/92 and 48/54 approached experts, respectively. There was broad agreement on diagnostic standards, multimodal approaches and focus on adverse events, but uncertainty in terms of pharmacological strategies (including clozapine) in case of failure and antipsychotic dosing in younger patients. Conclusion: Despite knowledge about diagnostic clues and integrated management of EOS, this study highlights the lack of standardization in treating EOS, with safety arguments having a major role in the decision-making process. Targeted clinical trials and systematic dissemination across Europe of current scientific evidence on the value of early intervention services is hoped to contribute to standardized and improved quality care for patients with early-phase psychosis and schizophrenia. © 2022 Correll et al.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback